Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis.

Chenyang Zhao Zhao Cui Yimiao Zhang Fang Wang Xin Wang Xuyang Cheng Liqiang Meng Gang Liu Minghui Zhao

Chin Med J (Engl)

Renal Division, Peking University First Hospital, Institute of Nephrology, Peking University; Key Laboratory of Renal Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China, Beijing 100034, China.

Published: April 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276299	PMC
http://dx.doi.org/10.1097/CM9.0000000000001855	DOI Listing

Publication Analysis

Top Keywords

leflunomide therapy

therapy adult

adult patients

patients steroid-dependent

steroid-dependent minimal

minimal change

change disease

disease primary

primary focal

focal segmental

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!